Maximus - MMS Stock Forecast, Price & News

Maximus' stock was trading at $79.67 on January 1st, 2022. Since then, MMS stock has decreased by 12.6% and is now trading at $69.61.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our MMS earnings forecast.

Maximus, Inc. (NYSE:MMS) issued its earnings results on Monday, November, 21st. The health services provider reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $0.38. The health services provider earned $1.18 billion during the quarter, compared to the consensus estimate of $1.09 billion. Maximus had a trailing twelve-month return on equity of 17.59% and a net margin of 4.40%.

Maximus announced a quarterly dividend on Monday, October 10th. Shareholders of record on Tuesday, November 15th will be given a dividend of $0.28 per share on Wednesday, November 30th. This represents a $1.12 annualized dividend and a dividend yield of 1.61%. The ex-dividend date is Monday, November 14th.
Read our dividend analysis for MMS.

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.57%. The dividend payout ratio is 34.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 25.87% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

Maximus issued an update on its FY 2023 earnings guidance on Tuesday, November, 22nd. The company provided earnings per share (EPS) guidance of $3.70-$4.00 for the period, compared to the consensus estimate of $3.36. The company issued revenue guidance of $4.75 billion-$4.90 billion, compared to the consensus revenue estimate of $4.65 billion.

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Maximus' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.14%), Victory Capital Management Inc. (10.05%), Vanguard Group Inc. (9.94%), Alliancebernstein L.P. (4.45%), Mackenzie Financial Corp (4.26%) and State Street Corp (4.22%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends.

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMS stock can currently be purchased for approximately $69.61.

Maximus (NYSE:MMS) has a market capitalization of $4.23 billion and generates $4.63 billion in revenue each year. The health services provider earns $203.83 million in net income (profit) each year or $3.29 on an earnings per share basis.

The company employs 39,500 workers across the globe.

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.